IRCT20200322046833N1已完成3 期
Evaluation of the efficacy and safety of Umifenovir in the treatment of hospitalized patients with covid-19: A randomized clinical trial
Center for Progress and Development of Iran0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age >18 years old
- •Patients with a probable and definitive diagnosis of COVID-19 who are candidates for hospitalization and receiving antiviral regimens.
- •Presence of at least one clinical sign (including fever, chills, cough, myalgia) with positive virologic specimen or imaging findings for COVID-19
排除标准
- •Patient or fellows' dissatisfaction with entering or continuing the study
- •History or any signs of hypersensitivity to umifenovir
- •Pregnancy and lactation
研究者
相似试验
招募中
3 期
Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19IRCT20080901001165N46Center for Progress and Development of Iran200
已完成
3 期
Effect of Umifenovir in treatment of covid-19IRCT20200523047550N1Tehran University of Medical Sciences50
招募中
3 期
Evaluating the effects of Umifenovir (Arbidol) in COVID-19IRCT20151227025726N15Shahid Beheshti University of Medical Sciences100
招募中
4 期
The study to evaluate the efficacy and safety of using Platelet-rich plasma combined with hyaluronic acid for treating neck rejuvenation in Thailand.HealthyPlatelet-rich plasma, neck rejuvenation, hyaluronic acidTCTR20230212003ASTRACO MEDICAL NETWORKS LTD.32
已完成
4 期
The study to evaluate the efficacy and safety of using hyaluronic acid filler to enhance lips in Thailand, Pilot studyips volumn lossHyaluronic acid, Filler, LipsTCTR20220528006Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand20